%A Aresu,Luca %D 2016 %J Frontiers in Veterinary Science %C %F %G English %K DLBCL,dog,Lymphoma,Methylation,Copy Number Variations,Transcription, Genetic %Q %R 10.3389/fvets.2016.00077 %W %L %M %P %7 %8 2016-August-31 %9 Mini Review %+ Luca Aresu,Department of Comparative Biomedicine and Food Science, University of Padova,Italy,luca.aresu@unito.it %# %! Canine lymphoma: the story of diffuse large b cell lymphoma %* %< %T Canine Lymphoma, More Than a Morphological Diagnosis: What We Have Learned about Diffuse Large B-Cell Lymphoma %U https://www.frontiersin.org/articles/10.3389/fvets.2016.00077 %V 3 %0 JOURNAL ARTICLE %@ 2297-1769 %X Diffuse large B-cell lymphoma (DLBCL) is the most common canine aggressive B-cell lymphoma worldwide, and new recent molecular approaches have shown that DLBCL constitutes a heterogeneous tumor that cannot be unraveled by morphology and immunophenotype. DLBCL behaves aggressively, typically progressing over a short period of time, and the therapy response may be difficult to be predicted. Recently, the rate of bone marrow infiltration by flow cytometry has been demonstrated to be prognostic, but more sensible markers are needed. As the clinical behavior is different, there is vast clinical and basic research devoted to identifying prognostically or biologically distinct DLBCL subgroups. Transcriptomic analysis by gene expression profile, copy number variations by array comparative genomic hybridization and epigenetic perturbations have tentatively described this heterogeneity. Molecular subgroups using oncogenic pathways and target genes have also been correlated to different outcome in a small number of cases. The objectives of this review are to summarize the current knowledge on the biology, clinical, and pathological characteristics of canine DLBCL. To date, DLBCL probably is the most investigated tumor in veterinary medicine, and its relevance as spontaneous model for human DLBCL has been confirmed by these studies. In future, these discoveries will ultimately lead to a better understanding of the underlying disease mechanisms, possibly translating into more effective therapeutic strategies.